Keros Therapeutics, Inc. (KROS) vs MacroGenics, Inc. (MGNX)
A side-by-side comparison of Keros Therapeutics, Inc. and MacroGenics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KROS
Keros Therapeutics, Inc.
$11.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MGNX
MacroGenics, Inc.
$3.64HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KROS vs MGNX
growth of $100 · dividends reinvested · last 6yKROS -42.6% (-8.8%/yr)MGNX -32.1% (-6.2%/yr)MGNX compounded faster over this window
KROS MGNX
KROS vs MGNX: by the numbers
- •MGNX is the larger company ($231M vs $218M market cap).
- •Both run net losses; MGNX's is the smaller (-8.70% vs -553.88% net margin).
- •KROS grew revenue faster over the past five years (172.50% vs 7.33% CAGR).
Metrics side by side
Valuation
| Metric | KROS | MGNX |
|---|---|---|
| P/S ratio | 14.54 | 1.38 |
| P/B ratio | 0.83 | 5.40 |
Profitability
| Metric | KROS | MGNX |
|---|---|---|
| Gross margin | 94.68% | 71.12% |
| Operating margin | 28.94% | -48.72% |
| Net margin | -553.88% | -8.70% |
| ROE | -31.70% | -34.04% |
| ROIC | -36.49% | -16.87% |
Growth (annualized)
| Metric | KROS | MGNX |
|---|---|---|
| Revenue CAGR (5Y) | 172.50% | 7.33% |
| Total return CAGR (5Y) | -21.98% | -28.42% |
Frequently asked
- Which has grown faster, KROS or MGNX?
- Over the past five years, KROS grew revenue faster — KROS at a 172.50% CAGR versus MGNX at 7.33%.
- How have KROS and MGNX total returns compared?
- Over the past 5 years, KROS delivered -21.98% and MGNX delivered -28.42% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Keros Therapeutics ROEMacroGenics ROEKeros Therapeutics operating marginMacroGenics operating marginKeros Therapeutics revenue growthMacroGenics revenue growthKeros Therapeutics free cash flowMacroGenics free cash flow
Keros Therapeutics & MacroGenics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.